We are proud to present our new team member – Stefan Almestrand.
Stefan studied chemical engineering and biotechnology at Mälardalen University and at the Royal institute of technology in Stockholm, Sweden. He spent 4 years in genomics and proteomics research focusing on hematological malignancies from Karolinska institutet. Following his research career, Stefan went to industry and has been working in EMEA and globally the last 10 years with sales, partnering, market and business development towards clinical diagnostics, precision medicine and companion diagnostics.
Stefan is advising on commercial strategy and tactics as well as in commercial operations and execution.